Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 682 of 1,261

  1. US 9402841

    Pyridinyl and fused pyridinyl triazolone derivatives

    Takeda Pharmaceutical Company Limited · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  2. US 9402898

    Stabilized formulations containing anti-Ang2 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  3. US 9402881

    Tissue regeneration and wound treatment methods with platelet derived compositions

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  4. US 9403911

    Compositions and methods for detection and treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  5. US 9402820

    Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  6. US 9403755

    Isometheptene isomer

    TONIX PHARMA HOLDINGS LIMITED (BERMUDA) · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  7. US 9403792

    Methods of using pyruvate kinase activators

    Agios Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  8. US 9403801

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  9. US 2016213609

    OPHTHALMIC SUSPENSION COMPOSITION

    BAUSCH & LOMB [US] · Granted Jul 28, 2016 · Expires Jul 23, 2036

    granted

  10. US 9399674

    Human antibodies to Clostridium difficile toxins

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  11. US 9399648

    Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  12. US 9399133

    Non-invasive automated electrical control systems and methods for monitoring animal conditions

    Rhode Island Board of Education, State of Rhode Island and Providence Plantations · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  13. US 9399034

    Methods of sedation during critical care treatment

    OVID THERAPEUTICS INC. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  14. US 9399637

    Substituted heteroaryl compounds and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  15. US 9399070

    Compositions comprising a polymeric reagent and a pharmacologically active agent

    Nektar Therapeutics · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  16. US 9399649

    Compounds for treating spinal muscular atrophy

    PTC THERAPEUTICS, INC. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  17. US 9399625

    Acridone compounds

    The United States of America · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  18. US 9399627

    Substituted macrocyclic compounds having proteasome inhibitory activity

    The Regents of the University of California · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  19. US 9399033

    Oligomer-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  20. US 9399639

    Substituted azaindole compounds, salts, pharmaceutical compositions thereof and methods of use

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  21. US 9399775

    RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases

    Alnylam Pharmaceuticals, Inc. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  22. US 9399774

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  23. US 9399662

    Concurrent chemotherapy and immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  24. US 9399672

    Hepatitis C virus neutralizing antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.